AMP Capital Investors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
AMP Capital Investors's RGEN Position: Q4 2021 in Review
AMP Capital Investors sold out of Repligen (RGEN) in Q4 2021, closing a stake of 2,854 shares — an estimated $825K sold.
AMP Capital Investors first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $825K in Q3 2021. 508 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.
- AMP Capital Investors reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 2,854 Repligen shares in Q4 2021, an estimated $825K.
- AMP Capital Investors first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
- AMP Capital Investors's Repligen position peaked at $825K in Q3 2021.
- 508 funds tracked by Wall St. Rank held Repligen as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.